MPT Product Development Database

This database includes MPT products that are currently available, as well as MPT products in active development. The database outlines detailed product information and can be searched to display products by desired criteria as selected from the drop-down boxes or by entering a keyword in the search box. Click on the product name to access detailed information on each product. Click here to learn more about the inclusion criteria and information update methodology.
Know of an MPT product not included in this database or have updated information for listed products? Let us know here!
Click on the table for MPT products in the development pipeline by indication combination.
Hormonal/Non-HormonalDelivery RouteDelivery MethodDevelopment Stage
       
IndicationProduct DeveloperProduct Sponsor/FundingActive Ingredient
       
Key Word Search   
       

30 product(s) found

Results: 30 product(s) found
3D Printed IVR
MPT in Development
Hormonal Topical Intravaginal Ring (IVR)
  • Acyclovir
  • Levonorgestrel
  • Tenofovir Disoproxil Fumarate (TDF)
  • University of North Carolina, Chapel Hill
  • P1
  • HIV
  • HSV-2
  • Pregnancy
  • Amphora Gel
    MPT in Development
    Non-Hormonal Topical Gel-Vaginal
  • Citric Acid
  • L-lactic Acid
  • Potassium Bitartrate
  • Evofem Inc.
  • C3
  • Chlamydia
  • Gonorrhea
  • Pregnancy
  • Co-formulated oral contraceptive MPT
    MPT in Development
    Hormonal Systemic Pill/Capsule/Tablet- Oral
  • Combined Oral Contraceptive (COC)
  • Emtricitabine (FTC)
  • Tenofovir Disoproxil Fumarate (TDF)
  • Population Council
  • C4
  • HIV
  • Pregnancy
  • Dapivirine + Levonorgestrel IVR
    MPT in Development
    Hormonal Topical Intravaginal Ring (IVR)
  • Dapivirine
  • Levonorgestrel
  • International Partnership for Microbicides (IPM)
  • C1
  • HIV
  • Pregnancy
  • Elvitegravir + Copper IUS
    MPT in Development
    Non-Hormonal Systemic Intrauterine Reservoir Devices
  • Copper
  • Elvitegravir
  • CONRAD
  • P2
  • HIV
  • Pregnancy
  • Etonogestrel + Ethinyl Estradiol + QGriffithsin IVR (EEQ IVR) [PC-8500]
    MPT in Development
    Hormonal Topical Intravaginal Ring (IVR)
  • Etonogestrel
  • Ethinyl Estradiol
  • QGriffithsin (QGRFT)
  • Oak Crest Institute
  • Population Council
  • P2
  • HIV
  • HPV
  • HSV-2
  • Pregnancy
  • Griffithsin (GRFT) in Carrageenan gel (PC-6500)
    MPT in Development
    Does Not Apply Topical Gel-Vaginal
  • Griffithsin (GRFT)
  • Population Council
  • C1
  • HIV
  • HPV
  • HSV-2
  • Griffithsin Gel
    MPT in Development
    Does Not Apply Topical Gel-Rectal
  • Griffithsin (GRFT)
  • University of Louisville
  • P1
  • Chlamydia
  • HIV
  • HSV-2
  • HCA + VRC01 + N6 IVR
    MPT in Development
    Non-Hormonal Topical Intravaginal Ring (IVR)
  • HCA
  • Monoclonal Antibodies
  • VRC01 + N6
  • MUCOMMUNE LLC
  • P2
  • HIV
  • Pregnancy
  • HER102
    MPT in Development
    Non-Hormonal Topical Fast Dissolve Insert/Capsule-Vaginal
  • Lactobacillus
  • Other
  • Hervana Bio
  • P1
  • Bacterial Vaginosis (BV)
  • Gonorrhea
  • Pregnancy
  • mAb 2C7 + TDF IVR
    MPT in Development
    Does Not Apply Topical Intravaginal Ring (IVR)
  • Monoclonal Antibodies
  • Tenofovir Disoproxil Fumarate (TDF)
  • MassBiologics
  • Oak Institute of Science
  • Planet Biotechnology, Inc.
  • University of Massachusetts
  • P1
  • Gonorrhea
  • HIV
  • MB66 Film
    MPT in Development
    Does Not Apply Topical Film - Vaginal
  • Monoclonal Antibodies
  • Mapp Biopharmaceutical, Inc.
  • C1
  • HIV
  • HSV-2
  • MB66+ Film
    MPT in Development
    Non-Hormonal Topical Film - Vaginal
  • Monoclonal Antibodies
  • Mapp Biopharmaceutical, Inc.
  • ZabBio, Inc.
  • C0
  • HIV
  • HSV-2
  • Pregnancy
  • MIV-150 and zinc acetate in a carrageenan gel (PC-1005) + SILCS (Caya) diaphragm
    MPT in Development
    Non-Hormonal Barrier with Drug Diaphragm
  • Carrageenan
  • MIV-150
  • Zinc Acetate
  • CONRAD
  • Kessel
  • PATH
  • Population Council
  • C2
  • HIV
  • HPV
  • HSV-2
  • Pregnancy
  • MIV-150 and zinc acetate in carrageenan gel (PC-1005)
    MPT in Development
    Does Not Apply Topical Gel-Vaginal;Rectal
  • Carrageenan
  • MIV-150
  • Zinc Acetate
  • Population Council
  • C2
  • HIV
  • HPV
  • HSV-2
  • MPT Microarray Patch (MAP)
    MPT in Development
    Hormonal Systemic Microarray Patch
  • Cabotegravir
  • Norelgestromin
  • PATH
  • P1
  • HIV
  • Pregnancy
  • OB-001
    MPT in Development
    Non-Hormonal Topical Gel-Vaginal
  • Matrine
  • Octoxynol-9
  • Orion Biotechnology
  • P2
  • HIV
  • Pregnancy
  • Over-encapsulated oral contraceptive MPT
    MPT in Development
    Hormonal Systemic Pill/Capsule/Tablet- Oral
  • Combined Oral Contraceptive (COC)
  • Emtricitabine (FTC)
  • Tenofovir Disoproxil Fumarate (TDF)
  • Population Council
  • C4
  • HIV
  • Pregnancy
  • poly-[1,4-phenylene-(1-carboxy) methylene] (PPCM) SAMMA Gel
    MPT in Development
    Non-Hormonal Topical Gel-Vaginal
  • poly-[1,4-phenylene-(1-carboxy) methylene
  • Yaso Therepeutics
  • P2
  • Chlamydia
  • Gonorrhea
  • HIV
  • HPV
  • HSV-2
  • Pregnancy
  • QGriffithsin (QGRFT)/Carrageenan (CG) fast dissolve insert
    MPT in Development
    Does Not Apply Topical Fast Dissolve Insert/Capsule-Vaginal
  • Carrageenan
  • QGriffithsin (QGRFT)
  • PATH
  • Population Council
  • P2
  • HIV
  • HPV
  • HSV-2
  • QGriffithsin/Carrageenan (QC) IVR
    MPT in Development
    Does Not Apply Topical Intravaginal Ring (IVR)
  • Carrageenan
  • QGriffithsin (QGRFT)
  • Population Council
  • P1
  • HIV
  • HPV
  • HSV-2
  • SR-2P Gel
    MPT in Development
    Does Not Apply Topical Gel-Vaginal
  • Acyclovir
  • SR-2P (Bioadhesive Polymer Gel)
  • Tenofovir (TFV)
  • SRI International
  • P1
  • HIV
  • HSV-2
  • Subcutaneous Contraceptive and HIV Implant Engineered for Long-Acting Delivery (SCHIELD) device
    MPT in Development
    Hormonal Systemic Implant (Subcutaneous)
  • Unspecified
  • Research Triangle International (RTI)
  • P1
  • HIV
  • Pregnancy
  • TAF / Elvitegravir Topical Insert
    MPT in Development
    Does Not Apply Topical Fast Dissolve Insert – Vaginal, Rectal
  • Elvitegravir
  • Tenofovir Alafenamide (TAF)
  • CONRAD
  • C1
  • HIV
  • HSV-2
  • TDF + FTC + Acyclovir + Ethinyl Estradiol + Etonogestrel IVR
    MPT in Development
    Hormonal Topical Intravaginal Ring (IVR)
  • Acyclovir
  • Emtricitabine (FTC)
  • Etonogestrel
  • Ethinyl Estradiol
  • Tenofovir Disoproxil Fumarate (TDF)
  • Auritec Pharmaceuticals
  • P2
  • HIV
  • HSV-2
  • Pregnancy
  • Tenofovir / Acyclovir IVR
    MPT in Development
    Does Not Apply Topical Intravaginal Ring (IVR)
  • Acyclovir
  • Tenofovir (TFV)
  • CONRAD
  • P2
  • HIV
  • HSV-1
  • HSV-2
  • Tenofovir + Levonorgestrel IVR
    MPT in Development
    Hormonal Topical Intravaginal Ring (IVR)
  • Levonorgestrel
  • Tenofovir (TFV)
  • CONRAD
  • C1
  • HIV
  • HSV-2
  • Pregnancy
  • Tenofovir Disoproxil Fumarate (TDF) IVR
    MPT in Development
    Does Not Apply Topical Intravaginal Ring (IVR)
  • Tenofovir Disoproxil Fumarate (TDF)
  • Albert Einstein College of Medicine
  • C1
  • HIV
  • HSV-2
  • Tenofovir IVR
    MPT in Development
    Does Not Apply Topical Intravaginal Ring (IVR)
  • Tenofovir (TFV)
  • CONRAD
  • C1
  • HIV
  • HSV-2
  • VivaGel® Vaginal Gel
    MPT in Development
    Does Not Apply Topical Gel-Vaginal
  • SPL7013 (Astodrimer Sodium)
  • Starpharma Pty Limited
  • P2
  • Bacterial Vaginosis (BV)
  • HIV
  • HSV-2
  • IMPT Secretariat
    1750 Howe Avenue, Suite 550
    Sacramento, CA 95825
    This email address is being protected from spambots. You need JavaScript enabled to view it.

    © Copyright 2019, Public Health Institute / CAMI Health / IMPT Secretariat. All rights reserved.

    The Initiative for Multipurpose Prevention Technologies (IMPT) is a project of CAMI Health, an organization dedicated to advancing the comprehensive sexual and reproductive health of women and girls worldwide. CAMI Health is housed at the Public Health Institute (PHI).

    This project is made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of Cooperative Agreement #AID-OAA-A-16-00045. The contents are the responsibility of the IMPT, CAMI Health, PHI, and its partners and do not necessarily reflect the views of USAID or the U.S. Government.
    PEPFAR USAID PHI CAMI Health